Parvosin ERY, emulzija za injekciju, za svinje
Parvosin ERY, emulzija za injekciju, za svinje
Authorised
- Erysipelothrix rhusiopathiae, serotype 1 and 2, Inactivated
- Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Product identification
Medicine name:
Parvosin ERY, emulzija za injekciju, za svinje
Active substance:
- Erysipelothrix rhusiopathiae, serotype 1 and 2, Inactivated
- Porcine parvovirus, strain CAPM V198 S-27, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 1 and 2, Inactivated1.00relative potency2.00millilitre(s)
-
Porcine parvovirus, strain CAPM V198 S-27, Inactivated4.00log2 haemagglutination inhibiting unit(s)2.00millilitre(s)
Pharmaceutical form:
-
Emulsion for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/21-01/447
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 22/04/2025
How useful was this page?: